share_log

HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Raises Price Target to $15

Benzinga ·  Mar 13 06:46

HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $12 to $15.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment